A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
NCT00089869 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2006-07-20
Summary
Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa
Conditions
Interventions
- DRUG
- DRUG
-
atomoxetine
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
NCT03892889 ·Status: TERMINATED ·Phase: PHASE3
-
Phase IIA Study in Patients With Schizophrenia
NCT00686998 ·Status: COMPLETED ·Phase: PHASE2
-
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
NCT00485498 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term, Open-Label, Study on Schizophrenia
NCT01129674 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study of Olanzapine in Patients With Schizophrenia
NCT00970281 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
NCT04109950 ·Status: TERMINATED ·Phase: PHASE3
-
A Study for Patients With Schizophrenia
NCT00520923 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCT00802100 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia
NCT00088478 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
NCT00712686 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Study in Schizophrenia
NCT01487083 ·Status: TERMINATED ·Phase: PHASE3
-
An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia
NCT00412620 ·Status: TERMINATED ·Phase: PHASE2
-
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
NCT00051298 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCT00423878 ·Status: COMPLETED ·Phase: PHASE4
-
Conversion to Antipsychotic Monotherapy
NCT01368458 ·Status: TERMINATED ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia
NCT02724917 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
NCT00202293 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
NCT01760993 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
NCT05628103 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
NCT00034580 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia
NCT01043458 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)
NCT00827918 ·Status: COMPLETED ·Phase: PHASE2
-
Antipsychotic Polypharmacy in Schizophrenia
NCT00493233 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
NCT00402324 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)
NCT00151424 ·Status: COMPLETED ·Phase: PHASE3